Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,279 | 302 | 49.8% |
| Consulting Fee | $3,475 | 1 | 32.8% |
| Travel and Lodging | $1,730 | 4 | 16.3% |
| Education | $109.39 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $5,492 | 22 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $453.83 | 33 | $0 (2023) |
| Amgen Inc. | $425.32 | 24 | $0 (2023) |
| Janssen Biotech, Inc. | $363.68 | 18 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $316.13 | 21 | $0 (2023) |
| Celgene Corporation | $286.28 | 17 | $0 (2023) |
| PFIZER INC. | $263.50 | 24 | $0 (2023) |
| GlaxoSmithKline, LLC. | $207.39 | 10 | $0 (2023) |
| Seattle Genetics, Inc. | $176.71 | 6 | $0 (2018) |
| Lilly USA, LLC | $171.80 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.74 | 1 | Myriad Genetic Laboratories, Inc. ($21.74) |
| 2023 | $1,021 | 47 | GlaxoSmithKline, LLC. ($129.20) |
| 2022 | $712.06 | 33 | SANOFI-AVENTIS U.S. LLC ($99.95) |
| 2021 | $232.78 | 11 | Seagen Inc. ($56.14) |
| 2020 | $170.40 | 9 | Amgen Inc. ($105.51) |
| 2019 | $269.90 | 15 | Janssen Biotech, Inc. ($70.60) |
| 2018 | $6,153 | 71 | Eisai Inc. ($5,381) |
| 2017 | $2,012 | 124 | E.R. Squibb & Sons, L.L.C. ($230.68) |
All Payment Transactions
311 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: Hematology | ||||||
| 08/02/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Oncology | ||||||
| 07/27/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: Oncology | ||||||
| 07/25/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Oncology | ||||||
| 07/20/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Oncology | ||||||
| 07/18/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $42.46 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: ONCOLOGY | ||||||
| 07/13/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Oncology | ||||||
| 07/10/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.04 | General |
| Category: Hematology | ||||||
| 06/30/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Oncology | ||||||
| 06/27/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Oncology | ||||||
| 06/20/2023 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: BioOncology | ||||||
| 06/13/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2023 | PFIZER INC. | INLYTA (Drug), BAVENCIO, XTANDI | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Oncology | ||||||
| 06/05/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.80 | General |
| Category: Oncology | ||||||
| 06/01/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Oncology | ||||||
| 05/25/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Oncology | ||||||
| 05/11/2023 | PFIZER INC. | BOSULIF (Drug), BESPONSA | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 698 | 1,460 | $412,969 | $113,516 |
| 2022 | 5 | 640 | 1,526 | $408,435 | $120,042 |
| 2021 | 7 | 757 | 1,860 | $442,790 | $150,356 |
| 2020 | 6 | 844 | 1,863 | $305,631 | $123,510 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 443 | 1,103 | $299,859 | $77,504 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 116 | 215 | $73,030 | $23,644 | 32.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 58 | 58 | $17,802 | $5,747 | 32.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 29 | 29 | $10,770 | $4,064 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 40 | 42 | $9,129 | $1,917 | 21.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 12 | 13 | $2,379 | $639.24 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 435 | 1,161 | $288,958 | $81,067 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 130 | 290 | $97,099 | $31,187 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 41 | 41 | $12,198 | $4,143 | 34.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 21 | 21 | $7,966 | $2,967 | 37.2% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 13 | 13 | $2,214 | $679.45 | 30.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 458 | 1,396 | $307,723 | $100,972 | 32.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 129 | 288 | $89,320 | $32,555 | 36.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 47 | 47 | $17,520 | $7,020 | 40.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 62 | 62 | $18,619 | $5,944 | 31.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 30 | 33 | $5,049 | $1,786 | 35.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 11 | $2,420 | $1,063 | 43.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 20 | 23 | $2,139 | $1,015 | 47.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 464 | 1,307 | $193,252 | $76,790 | 39.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 159 | 315 | $64,203 | $27,656 | 43.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 116 | 116 | $28,378 | $11,405 | 40.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 40 | 50 | $7,458 | $3,057 | 41.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 17 | 17 | $4,903 | $2,254 | 46.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 27 | 37 | $5,661 | $1,505 | 26.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 21 | 21 | $1,776 | $842.67 | 47.4% |
About Dr. Junfeng Wang, M.D
Dr. Junfeng Wang, M.D is a Hematology & Oncology healthcare provider based in Mount Vernon, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154533412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Junfeng Wang, M.D has received a total of $10,593 in payments from pharmaceutical and medical device companies, with $21.74 received in 2024. These payments were reported across 311 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($5,279).
As a Medicare-enrolled provider, Wang has provided services to 2,939 Medicare beneficiaries, totaling 6,709 services with total Medicare billing of $507,424. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology
- Location Mount Vernon, WA
- Active Since 05/07/2007
- Last Updated 08/15/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154533412
Products in Payments
- Lenvima (Drug) $5,415
- OPDIVO (Biological) $314.86
- ADCETRIS (Biological) $221.23
- ZEJULA (Drug) $179.33
- DARZALEX (Biological) $157.88
- IMBRUVICA (Drug) $156.12
- KEYTRUDA (Biological) $136.32
- JAKAFI (Drug) $135.48
- IBRANCE (Drug) $133.59
- CYRAMZA (Drug) $128.33
- ELITEK (Biological) $116.77
- FOUNDATIONONE (Device) $114.57
- Abraxane (Drug) $112.29
- Nplate (Biological) $102.97
- XTANDI (Drug) $92.02
- ERLEADA (Drug) $90.64
- KISQALI (Drug) $85.84
- INJECTAFER (Drug) $82.36
- NINLARO (Drug) $78.48
- Halaven (Drug) $76.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Mount Vernon
Jaideep Shenoi, Md, MD
Hematology & Oncology — Payments: $75,285
Kiarash Kojouri, M.d, M.D
Hematology & Oncology — Payments: $17,504
Hammad Shafqat, Md, MD
Hematology & Oncology — Payments: $1,747
Dr. Yagnesh Oza, M.d, M.D
Hematology & Oncology — Payments: $901.88
Bruce Mathey, Md, MD
Hematology & Oncology — Payments: $806.10
Dr. Geetha Naik, Md, MD
Hematology & Oncology — Payments: $13.86